Mitchell Shirvan insider trades

Open-market stock purchases and sales by Mitchell Shirvan, CSO and CDO at Silexion Therapeutics Corp, from SEC Form 4 filings since Jan 1, 2018.

Recent trades

DateStockTradeValue
Jun 4, 2026SLXN Silexion Therapeutics CorpBought (not open market)—
Mar 26, 2026SLXN Silexion Therapeutics CorpSold$31K
Feb 20, 2026SLXN Silexion Therapeutics CorpBought (not open market)—

Companies traded

  • SLXN Silexion Therapeutics Corp: 1 sale, last Jun 4, 2026
  • FOMX Foamix Pharmaceuticals Ltd: other filings, last Feb 27, 2018

Get free alerts when Mitchell Shirvan files a new trade →